Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria
Beijing Center for Disease Prevention and Control
1 other identifier
observational
76,220
1 country
11
Brief Summary
Through two-stage stratified cluster sampling, investigators studied the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infection-related liver disease population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Typical duration for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2020
CompletedFirst Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 11, 2020
CompletedFebruary 11, 2020
February 1, 2020
2.2 years
February 4, 2020
February 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HBsAg positive rate
Complete HBsAg tests for more than 60,000 people over the age of 25 in Beijing
Baseline
Average rate of chronic hepatitis B accepting antiviral treatment
The one who is eligible for HBV treated criteria based on community in 25 and over years old in Beijing.
Baseline
Eligibility Criteria
The study population are Residents with medical insurance who were older than 25 years and lived in Beijing more than 6 months. The population who are with pacemakers and ascites, pregnant, and whose wound was not cured at right upper abdomen were excluded.
You may qualify if:
- older than 25 years old;
- Residents with medical insurance coverage lived in Beijing more than 6 months .
You may not qualify if:
- Persons with pacemakers;
- Pregnant women;
- Persons with ascites;
- The one whose wound was not cured at the right upper abdomen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wu Jianglead
Study Sites (11)
Xicheng District Center for Disease Prevention and Control
Beijing, Beijing Municipality, 100120, China
Huairou District Center for Disease Prevention and Control
Beijing, Beijing Municipality, 101400, China
Daxing District Center for Disease Prevention and Control
Beijing, Beijing Municipality, 102600, China
Chaoyang District Center for Disease Control and Prevention
Beijing, Beijing Municipality, China
Dongcheng District Center for Disease Control and Prevention
Beijing, Beijing Municipality, China
Fengtai District Center for Disease Control and Prevention
Beijing, Beijing Municipality, China
Changping District Center for Disease Prevention and Control
Beijing, China
FangShan District Center for Disease Prevention and Control
Beijing, China
Haidian District Center for Disease Prevention and Control
Beijing, China
Miyun District Center for Disease Prevention and Control
Beijing, China
Tongzhou District Center for Disease Prevention and Control
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jiang Wu
Beijing Center for Disease Prevention and Control
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of institue for immunization and prevention of Beijing CDC
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 11, 2020
Study Start
July 28, 2017
Primary Completion
September 28, 2019
Study Completion
January 10, 2020
Last Updated
February 11, 2020
Record last verified: 2020-02